Yunnan Botanee Bio-Technology Group Co Ltd (300957) - Net Assets
Based on the latest financial reports, Yunnan Botanee Bio-Technology Group Co Ltd (300957) has net assets worth CN¥6.24 Billion CNY (≈ $913.17 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥8.29 Billion ≈ $1.21 Billion USD) and total liabilities (CN¥2.05 Billion ≈ $299.66 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how strategically is Yunnan Botanee Bio-Technology Group Co L's equity deployed to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥6.24 Billion |
| % of Total Assets | 75.29% |
| Annual Growth Rate | 48.79% |
| 5-Year Change | 31.94% |
| 10-Year Change | N/A |
| Growth Volatility | 91.96 |
Yunnan Botanee Bio-Technology Group Co Ltd - Net Assets Trend (2017–2025)
This chart illustrates how Yunnan Botanee Bio-Technology Group Co Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see 300957 company net worth.
Annual Net Assets for Yunnan Botanee Bio-Technology Group Co Ltd (2017–2025)
The table below shows the annual net assets of Yunnan Botanee Bio-Technology Group Co Ltd from 2017 to 2025. Also explore Yunnan Botanee Bio-Technology Group Co L (300957) net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥6.30 Billion ≈ $922.55 Million |
+1.89% |
| 2024-12-31 | CN¥6.19 Billion ≈ $905.47 Million |
+2.86% |
| 2023-12-31 | CN¥6.02 Billion ≈ $880.30 Million |
+7.38% |
| 2022-12-31 | CN¥5.60 Billion ≈ $819.80 Million |
+17.24% |
| 2021-12-31 | CN¥4.78 Billion ≈ $699.24 Million |
+297.60% |
| 2020-12-31 | CN¥1.20 Billion ≈ $175.86 Million |
+57.92% |
| 2019-12-31 | CN¥761.02 Million ≈ $111.36 Million |
+68.79% |
| 2018-12-31 | CN¥450.87 Million ≈ $65.98 Million |
+71.80% |
| 2017-12-31 | CN¥262.44 Million ≈ $38.40 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Yunnan Botanee Bio-Technology Group Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1445.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥2.99 Billion | 48.62% |
| Other Components | CN¥3.16 Billion | 51.38% |
| Total Equity | CN¥6.16 Billion | 100.00% |
Yunnan Botanee Bio-Technology Group Co Ltd Competitors by Market Cap
The table below lists competitors of Yunnan Botanee Bio-Technology Group Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CSSC Steel Structure Engineering Co Ltd
SHG:600072
|
$1.96 Billion |
|
Allied Blenders & Distillers Ltd
NSE:ABDL
|
$1.96 Billion |
|
Veridis Environment Ltd
TA:VRDS
|
$1.96 Billion |
|
Investis Holding SA
SW:IREN
|
$1.96 Billion |
|
Aecon Group Inc.
TO:ARE
|
$1.96 Billion |
|
Fulltech Fiber Glass
TWO:1815
|
$1.96 Billion |
|
China Meheco Co Ltd
SHG:600056
|
$1.96 Billion |
|
Beijing Jetsen Tech Co
SHE:300182
|
$1.96 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Yunnan Botanee Bio-Technology Group Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 6,049,901,389 to 6,157,265,025, a change of 107,363,636 (1.8%).
- Net income of 505,719,664 contributed positively to equity growth.
- Dividend payments of 265,638,494 reduced retained earnings.
- Other comprehensive income decreased equity by 229,344,663.
- Other factors increased equity by 96,627,129.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥505.72 Million | +8.21% |
| Dividends Paid | CN¥265.64 Million | -4.31% |
| Other Comprehensive Income | CN¥-229.34 Million | -3.72% |
| Other Changes | CN¥96.63 Million | +1.57% |
| Total Change | CN¥- | 1.77% |
Book Value vs Market Value Analysis
This analysis compares Yunnan Botanee Bio-Technology Group Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.17x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 44.78x to 2.17x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CN¥0.71 | CN¥31.59 | x |
| 2018-12-31 | CN¥1.23 | CN¥31.59 | x |
| 2019-12-31 | CN¥1.79 | CN¥31.59 | x |
| 2020-12-31 | CN¥2.83 | CN¥31.59 | x |
| 2021-12-31 | CN¥11.23 | CN¥31.59 | x |
| 2022-12-31 | CN¥13.11 | CN¥31.59 | x |
| 2023-12-31 | CN¥13.86 | CN¥31.59 | x |
| 2024-12-31 | CN¥14.43 | CN¥31.59 | x |
| 2025-12-31 | CN¥14.54 | CN¥31.59 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Yunnan Botanee Bio-Technology Group Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.21%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.44%
- • Asset Turnover: 0.64x
- • Equity Multiplier: 1.35x
- Recent ROE (8.21%) is below the historical average (31.68%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 60.26% | 19.25% | 1.59x | 1.97x | CN¥128.14 Million |
| 2018 | 58.53% | 21.00% | 1.62x | 1.72x | CN¥216.01 Million |
| 2019 | 54.47% | 21.19% | 1.79x | 1.43x | CN¥336.32 Million |
| 2020 | 45.33% | 20.61% | 1.57x | 1.40x | CN¥423.61 Million |
| 2021 | 18.15% | 21.45% | 0.69x | 1.22x | CN¥387.40 Million |
| 2022 | 18.93% | 20.97% | 0.75x | 1.21x | CN¥496.04 Million |
| 2023 | 12.91% | 13.21% | 0.76x | 1.28x | CN¥170.70 Million |
| 2024 | 8.32% | 8.77% | 0.69x | 1.37x | CN¥-101.94 Million |
| 2025 | 8.21% | 9.44% | 0.64x | 1.35x | CN¥-110.01 Million |
Industry Comparison
This section compares Yunnan Botanee Bio-Technology Group Co Ltd's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,593,545,143
- Average return on equity (ROE) among peers: 9.23%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Yunnan Botanee Bio-Technology Group Co Ltd (300957) | CN¥6.24 Billion | 60.26% | 0.33x | $1.96 Billion |
| Lonkey Industrial Co Ltd Guangzhou (000523) | $1.56 Billion | 4.80% | 1.06x | $910.51 Million |
| Tianjin Yiyi Hygiene Products Co Ltd (001206) | $1.81 Billion | 8.32% | 0.12x | $448.86 Million |
| Hunan Resun Co Ltd (001218) | $2.06 Billion | 5.82% | 0.30x | $458.70 Million |
| Qingdao Kingking Applied Chemistry Co Ltd (002094) | $3.37 Billion | 3.09% | 0.75x | $517.63 Million |
| C&S Paper Co Ltd (002511) | $3.04 Billion | 11.47% | 0.90x | $1.32 Billion |
| Anhui Deli Household Glass Co Ltd (002571) | $258.46 Million | 22.17% | 1.11x | $622.87 Million |
| Mingchen Health Co Ltd Class A (002919) | $537.52 Million | 9.02% | 0.27x | $653.87 Million |
| Chongqing Baiya Sanitary Products Co (003006) | $1.39 Billion | 17.18% | 0.36x | $1.33 Billion |
| Chengdu Rainbow Appliance Gr (003023) | $1.30 Billion | 8.64% | 0.44x | $393.39 Million |
| Fujian Green Pine Co Ltd (300132) | $600.32 Million | 1.82% | 0.50x | $464.14 Million |
About Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. It operates through Skin Care Products, Medical Instruments, and Makeup segments. The company offers face creams, toners, masks, serums, and lotions; and makeup products, including primers, powders, BB creams, and makeup … Read more